More prostate cancers are being diagnosed at a later stage
(HealthDay)—While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the […]
Home »
MONDAY, Oct. 5, 2020 — A daily, low dose of aspirin may increase the risk for progression and metastasis as well as mortality related to […] In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center’s […] Hope for triple negative breast cancer sufferers: Scientists STOP the aggressive disease from spreading in animal tests Triple negative breast cancer doesn’t respond to targeted […] Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers since they rarely have early symptoms. As a […] Cancer is a disease of dysregulated gene expression. Now, researchers from Jefferson (Philadelphia University + Thomas Jefferson University) find that a new, large category of […] Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen […] A new method developed by scientists at Johns Hopkins Bloomberg School of Public Health is likely to speed the study of an important biological process […] BOULDER, Colo., Jan. 10, 2019 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted […] Findings from a new study by researchers at the National Cancer Institute (NCI) show that patients treated with chemotherapy for most solid tumors during 2000-2014 […]
Daily Aspirin May Up Growth, Spread of Cancers in Older Adults
Researchers advance new therapy with potential benefit for underserved patients with lung and ovarian cancers
Scientists STOP triple negative breast cancer's spread in animal tests
Scientists develop promising drug for treating ovarian, pancreatic cancers
Fragments of cellular machinery reveal unexpected variability among cancers
Shared genetic marker offers new promise in targeting specific ovarian and lung cancers
A new toolkit for studying how ‘PARP’ activity boosts cancers
miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen
Study finds elevated risk of rare blood cancers after chemotherapy for most solid tumors